What is the current Europe Sodium-dependent Glucose Cotransporter 2 Market size?

In 2024, the Europe Sodium-dependent Glucose Cotransporter 2 Market size is expected to reach USD 1.30 billion. Read More

Who are the key players in Europe Sodium-dependent Glucose Cotransporter 2 Market?

Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals and Eli Lilly and Company are the major companies operating in the Europe Sodium-dependent Glucose Cotransporter 2 Market. Read More

What years does this Europe Sodium-dependent Glucose Cotransporter 2 Market cover, and what was the market size in 2023?

In 2023, the Europe Sodium-dependent Glucose Cotransporter 2 Market size was estimated at USD 1.18 billion. The report covers the Europe Sodium-dependent Glucose Cotransporter 2 Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Sodium-dependent Glucose Cotransporter 2 Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Sodium-dependent Glucose Cotransporter 2 Companies

Q: How big is the Europe Sodium-dependent Glucose Cotransporter 2 Market?

The Europe Sodium-dependent Glucose Cotransporter 2 Market size is expected to reach USD 1.30 billion in 2024 and grow at a CAGR of 9.10% to reach USD 2.02 billion by 2029. Read More

This report lists the top Europe Sodium-dependent Glucose Cotransporter 2 companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Europe Sodium-dependent Glucose Cotransporter 2 industry.